Skip to main content
Equibles

MORGAN STANLEY

Position in PDSB — PDS Biotechnology Corp

CIK 895421 NEW YORK, NY
Back to PDSB Full portfolio

Position in PDSB

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$276,564
+$274,192 QoQ
Shares Held
313,922
+7904.1% QoQ
Ownership
0.561%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 52 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in PDSB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. PDSB ranks #306 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in PDSB

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $276,564 313,922
2026-03-31 $2,372 3,922
2025-12-31 $3,789 4,922
2025-09-30 $8,341 8,259
2025-06-30 $9,886 7,434
2025-03-31 $20,604 17,315
2024-12-31 $29,166 17,894
2024-09-30 $104,788 27,432
2024-06-30 $216,780 73,988
2024-03-31 $288,171 72,771
2023-12-31 $423,173 85,146
2023-09-30 $347,528 68,818
2023-06-30 $338,372 67,271
2023-03-31 $638,737 103,860
2022-12-31 $2,953,300 223,735
2022-09-30 $45,797 15,420
2022-06-30 $52,453 14,371
2022-03-31 $102,907 16,625
2021-12-31 $165,644 20,450
2021-09-30 $85,317 5,726
2021-06-30 $824,571 65,703
2021-03-31 $12,694 2,790
2020-12-31 $3,638 1,700
2020-09-30 $14,213 6,100